Myelin Repair Foundation
Myelin Repair Foundation
The Myelin Repair Foundation (MRF) was a non-profit organization dedicated to accelerating the discovery and development of treatments for myelin repair in multiple sclerosis (MS) and other demyelinating diseases. Founded in 2002 by Scott Johnson, the foundation aimed to bridge the gap between basic research and clinical application.
Mission[edit | edit source]
The primary mission of the Myelin Repair Foundation was to develop a new model for medical research that would speed up the process of translating basic scientific discoveries into effective treatments. The foundation focused on myelin repair as a means to treat and potentially cure multiple sclerosis.
Research Model[edit | edit source]
The Myelin Repair Foundation pioneered a unique research model known as the Accelerated Research Collaboration (ARC) model. This model emphasized collaboration among scientists from different institutions and disciplines, with the goal of sharing data and resources to expedite the research process. The ARC model was designed to overcome the traditional barriers in medical research, such as competition and lack of communication between researchers.
Key Achievements[edit | edit source]
The Myelin Repair Foundation funded and coordinated research across several leading institutions, resulting in significant advancements in understanding myelin biology and repair mechanisms. Some of the key achievements include:
- Identification of potential therapeutic targets for myelin repair.
- Development of new assays and tools for studying myelin and its regeneration.
- Establishment of partnerships with pharmaceutical companies to translate research findings into clinical trials.
Closure[edit | edit source]
In 2014, the Myelin Repair Foundation announced that it would cease operations. The decision was made after a strategic review of the foundation's progress and the evolving landscape of myelin repair research. The foundation's contributions to the field have continued to influence ongoing research efforts in myelin repair and multiple sclerosis treatment.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
